Skip to main content
. 2016 Aug 28;2016(8):CD008815. doi: 10.1002/14651858.CD008815.pub4

Sivin 1998.

Methods Design: randomized controlled trial; focused on effectiveness of reformulated 2‐rod LNG implant versus 6‐rod implant
Location: 7 centers including USA and Finland
Time frame: enrollment 1990 to 1994
Sample size estimation and outcome of focus: assumed 50/100 acceptors would continue; pregnancy rate 2.0/100 at 3 years with SE 0.66/100; sample size could distinguish difference in pregnancy of 2/100 between 2 implant types
Participants 1200 healthy women, 18 to 40 years old, who sought implant contraception
Inclusion criteria: no contraindication to implant use; willing to undergo study procedures
Exclusion criteria: cancer; severe cardiovascular problem; hyperlipidemia; diabetes mellitus; mental illness; epilepsy; severe or frequent headaches; undiagnosed genital bleeding; hyperprolactinemia or bloody breast discharge; pelvic inflammatory disease since last pregnancy or ectopic pregnancy
Interventions Levonorgestrel implants
 1) Norplant: 6 capsules containing levonorgestrel 216 mg (total)
 2) LNG rod (Jadelle): 2 rods containing levonorgestrel 150 mg (total); different elastomer in core than earlier implant
 Follow‐up: 1, 3, 6 months; then semi‐annually to 5 years
Outcomes Mean weight change by implant group
 Weight change for 10th, 50th, and 90th percentiles of body weight (at admission)
Follow‐up: 5 years
Weighing method not specified
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Randomization by "linear congruential method"; blocks of 50 per clinic
Allocation concealment (selection bias) Low risk Implants in sealed opaque envelopes numbered sequentially according to randomization lists
Blinding of participants and personnel (performance bias) 
 All outcomes Unclear risk Not feasible due to apparent differences in interventions
Blinding of outcome assessment (detection bias) 
 All outcomes Unclear risk No information; objective outcome measures
Incomplete outcome data (attrition bias) 
 All outcomes High risk Loss to follow‐up: year 3, 2.7% each group; year 5, 7.2% LNG rod and 10.2% Norplant
Discontinuation: end of year 3, LNG rod 31.6% (190/600) and Norplant 31.2% (187/598); end of year 5, LNG rod 54.7% (328/600) and Norplant 60% (359/598)
2 sets of Norplant contaminated and not used (1198/2000 analyzed)